Exact Sciences Corporation - Common Stock (NQ:EXAS)

104.91 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

23 24 Next >

Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer

March 28, 2024

From Exact Sciences Corp.

Via Business Wire

3 Biotech Stocks to Buy on the Dip: March 2024 ↗

March 27, 2024

Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.

Via InvestorPlace

Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner

March 27, 2024

From Exact Sciences Corp.

Via Business Wire

3 Growth Stocks to Buy at 52-Week Lows in March ↗

March 26, 2024

Wager on these growth stocks to buy at 52-week lows offering robust investment potential ahead for savvy investors.

Via InvestorPlace

2 Beaten-Down Cathie Wood Stocks With Massive Potential ↗

March 11, 2024

They won't lag the market forever.

Via The Motley Fool

Earnings Scheduled For February 21, 2024 ↗

February 21, 2024

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.

Via Benzinga

Earnings Preview For Exact Sciences ↗

February 20, 2024

Via Benzinga

The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study

March 13, 2024

From Exact Sciences Corp.

Via Business Wire

Cathie Wood Darling Exact Sciences Could Pop After Its Next-Gen Product Outperforms ↗

March 13, 2024

Exact Sciences is hoping to launch an next-generation version of Cologuard in 2025.

Via Investor's Business Daily

5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024 ↗

March 09, 2024

Things have been looking better for the biotech industry in 2024 after a decent performance in 2023. Here is a look at some biotech stocks that may provide stability to one's portfolio throughout the...

Via Talk Markets

Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer

March 07, 2024

From Exact Sciences Corp.

Via Business Wire

Cathie Wood Is Selling This Stock: Should You? ↗

February 07, 2024

This company hasn't performed well in the past 12 months.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

March 06, 2024

Via Benzinga

The Top 3 Healthcare Stocks to Buy on Weakness in 2024 ↗

March 04, 2024

Many healthcare stocks have extremely bright outlooks and very low valuations. Here are three top healthcare stocks to buy.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

March 04, 2024

Via Benzinga

7 Stable Stocks to Buy for 100% Returns by 2025 ↗

March 04, 2024

If you're looking for stability and the opportunity to double your returns by the time 2025 rolls around, check out these stable stocks.

Via InvestorPlace

Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices ↗

March 03, 2024

While these underdogs stocks might not be on everyone’s radar, they may offer surprisingly robust upside potential.

Via InvestorPlace

3 Hot Stocks Bought by Members of Congress: Follow the Money

March 01, 2024

Palo Alto Networks, Simon Property Group and JPMorgan Chase are the top three stocks bought by Members of Congress in February;

Via MarketBeat

Exact Sciences to Participate in March Investor Conference

February 26, 2024

From Exact Sciences Corp.

Via Business Wire

Nasdaq, S&P 500 Futures Jump As Nvidia Surge Raises 'FOMO' Rally Hopes: Analyst Tells Why Jobs Data Holds Key For Momentum ↗

February 22, 2024

Market participants remain attentive to several factors shaping the day's trading landscape, including scheduled Fed speeches, weekly jobless claims data, and private-sector activity readings.

Via Benzinga

Topics Economy Stocks

Exact Sciences (EXAS) Q4 2023 Earnings Call Transcript ↗

February 22, 2024

EXAS earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Exact Sciences Announces Fourth Quarter 2023 Results

February 21, 2024

From Exact Sciences Corp.

Via Business Wire

Wall Street Waits With Bated Breath For Nvidia Earnings After Tech Selloff, Fed Minutes Eyed: Analyst Flags This As Biggest Risk For Market ↗

February 21, 2024

The market will broaden the sustenance of its rally when interest-rate cuts begin to be priced in and investors begin to think about the roadmap, an analyst said.

Via Benzinga

Topics Economy

2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge

February 02, 2024

--News Direct--

Via News Direct

Topics Death

2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge ↗

February 01, 2024

The global population is experiencing a scary increase in colorectal cancer, especially among young people. Colorectal cancer (CRC) diagnoses have been steadily rising since the 1990s; in 1995 the...

Via Benzinga

Topics Death

Exact Sciences Schedules Fourth Quarter 2023 Earnings Call

February 01, 2024

From Exact Sciences Corp.

Via Business Wire

3 Stocks to Buy for the Age of Personalized Medicine ↗

January 28, 2024

Personalized medicine stocks can unlock significant growth from your portfolio. Here are three companies to consider.

Via InvestorPlace

2 Cathie Wood Growth Stocks to Buy and Hold for the Long Haul ↗

January 22, 2024

These stocks can reward patient investors.

Via The Motley Fool

The Top 3 Stocks in the High-Potential ‘Cancer Testing’ Market ↗

January 18, 2024

With the value of the cancer testing market expected to soar over the next decade, here are the three best disease testing stocks to buy now.

Via InvestorPlace

Time to buy these 3 healthcare companies that raised revenue guidance?

January 16, 2024

The new year brings a clean slate heading into the fourth-quarter earnings season. Check out a few companies that have raised revenue guidance.

Via MarketBeat

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.